| 1 |
6 days |
Female |
Severely underweight |
Plasmodium falciparum
|
Neonatal sepsis (clinical diagnosis) |
Intravenous quinine |
Ampicillin |
38 days |
| 2 |
2 months |
Male |
Not recorded |
P. falciparum
|
Bronchopneumonia |
Intravenous quinine |
Ampicillin, gentamicin |
4 days |
| 3 |
2 months 17 days |
Male |
Not recorded |
P. falciparum
|
Bacterial meningitis (cerebrospinal fluid confirmed) |
Intravenous quinine |
Ampicillin, gentamicin |
6 days |
| 4 |
2 months 21 days |
Female |
Severely underweight |
P. falciparum
|
Coma, severe anemia, hypoglyce- mia, metabolic acidosis |
Intravenous quinine |
Ceftriaxone |
Within 24 h |
| 5 |
3 months |
Male |
Normal |
P. falciparum
|
Severe anemia with metabolic and respiratory acidosis |
No record of malaria treatment |
Ceftriaxone and gentamicin |
Within 24 h |
| 6 |
1 month 11 days |
Male |
Normal |
Plasmodium vivax
|
Coma |
Intravenous artesunate |
Ampicillin, gentamicin, ceftriaxone |
Within 24 h |
| 7 |
2 months 16 days |
Male |
Underweight |
P. vivax
|
Respiratory distress and severe anemia |
Intravenous artesunate and then oral dihydroartemisinin- piperaquine |
Ampicillin |
4 days |